The positive correlation between high GLP1R expression and improved survival in our study suggests that, while GLP-1 receptor agonists may increase the risk of developing thyroid cancer, those tumors with higher GLP1R expression could be more responsive to GLP-1R signaling, leading to better clinical outcomes. The gene discussed is GLP1R; the disease is thyroid cancer.